1. ALLA AKTIER
  2. NYHETER
  3. SURGICAL SCIENCE SWEDEN

Surgical Science Sweden

Nyheter Surgical Science Sweden Nyheter alla bolag

Surgical Science wins a procurement contract in Southeast Asia amounting to SEK 52 million – new product and new customer group

MAR

Surgical Science has received an order to deliver products to the defence ministry in a Southeast Asian country for approx. USD 4.7 million, corresponding to approx. SEK 52 million. The order is for 30 units of the new and enhanced TraumaVR product, for training military medical personnel in emergency situations, and in highly realistic and immersive visual environments.

The order includes both products and development work and is expected to be delivered and recognized as revenue over a period of 18 months. Work will commence immediately. This procurement is the one mentioned as ongoing in the quarterly reports for Q2 and Q3 in 2024.

With this order Surgical Science expands into a new market segment: defense and rescue services. This segment includes military personnel, police, firefighters, and other first responders, all of whom require robust training to develop and objectively validate practical life-saving skills for critical situations outside the hospital environment.

Surgical Science’s mission is to enhance patient safety and improve healthcare outcomes through advanced medical simulation. By expanding its solutions to support life-saving efforts in diverse scenarios, the company continues to fulfill its purpose.

“This order marks a significant breakthrough for a new product targeting a potentially very large customer segment. TraumaVR represents an innovative approach to developing critical technical skills through Virtual Reality, addressing an essential need in trauma training. This new product category is strategically important for us, and we hold high expectations for its future impact. Securing our first major order for TraumaVR is a gratifying achievement and a key milestone for our team," says Tom Englund, CEO of Surgical Science.

Gothenburg, Sweden, February 4, 2025
Surgical Science Sweden AB (publ)

This press release, in its entirety, is available through the attachment or via:
https://surgicalscience.com/investor-relations/#press-releases

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

For further information, please contact:

Tom Englund, CEO
Telephone: +46-70-916 16 81
E-mail: tom.englund@surgicalscience.com

Anna Ahlberg, CFO
Telephone: +46-70-855 38 35
E-mail: anna.ahlberg@surgicalscience.com

About Surgical Science Sweden AB (publ)

One of the biggest challenges within healthcare globally is reducing injuries incurred during care. Medical education and training are key, especially as a large part of the training can now be performed outside the operating room. Surgical Science is a world leader in the development of virtual reality simulators for evidence-based training. The simulators enable surgeons and other medical specialists to train and improve their psycho-motor skills and instrument handling before entering the clinical environment. Alongside its own products, Surgical Science works with simulation solutions for medical device companies that develop instruments for clinical use, such as robotic surgery.

Surgical Science has approximately 270 employees. The company is headquartered in Gothenburg, Sweden and also has operations in Tel Aviv, Israel, as well as in Stockholm, Sweden and in Seattle and Cleveland, US. Through sales offices in the US and China as well as a global network of distributors, Surgical Science maintains a presence in most markets. Shares in Surgical Science Sweden AB (publ) are traded on Nasdaq First North Growth Market. Certified Adviser is Carnegie Investment Bank AB (publ).

This information is information that Surgical Science Sweden AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-02-04 08:30 CET.

Attachments

Surgical Science wins a procurement contract in Southeast Asia amounting to SEK 52 million – new product and new customer group

Datum 2025-02-04, kl 08:30
Källa MFN
Bifogade filer
Surgical Science wins a procurement contract in Southeast Asia amounting to SEK 52 million – new product and new customer group
Affiliate
Alla Aktier tipsar: Har du redan ett konto på Avanza? Varför inte skapa ett på Nordnet också och jämföra funktioner, courtage mm. Det tar inte lång tid, du fixar det direkt här med BankID
Investeringar i värdepapper och fonder innebär alltid en risk och det är inte säkert att du får tillbaka det investerade kapitalet